APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tumor Treatment Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tumor Treatment Drug Industry Growth and Trends Forecast to 2032

2 January 2026124 pages

Choose your research edition.

Industry ResearchTumor Treatment Drug Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Treatment Drug Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Tumor Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Treatment Drug Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Treatment Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

According to APO Research, the global Tumor Treatment Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tumor Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tumor Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Tumor Treatment Drug market include Astellas, Biogen Idec, Bristol-Myers Squibb, Celgene, Gilead Sciences, Ipsen, Merck & Co., Otsuka and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tumor Treatment Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tumor Treatment Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor Treatment Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor Treatment Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Tumor Treatment Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tumor Treatment Drug Market by Company

Astellas

Biogen Idec

Bristol-Myers Squibb

Celgene

Gilead Sciences

Ipsen

Merck & Co.

Otsuka

AstraZeneca

AbbVie

Amgen

Bayer

Pfizer

Eli Lilly

Roche

Merck KGaA

Novartis

Johnson & Johnson

Sanofi

Teva

Eisai

Takeda

Tumor Treatment Drug Segment by Type

Immunotherapy (Biologic Therapy)

Chemotherapy

Hormonal Therapy

Targeted Therapy

Others

Tumor Treatment Drug Segment by Application

Respiratory/Lung Cancer

Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Blood Cancer

Others

Tumor Treatment Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Treatment Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Tumor Treatment Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Tumor Treatment Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Tumor Treatment Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Tumor Treatment Drug Market Share by Region (2021-2026) Table 4. Global Tumor Treatment Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Tumor Treatment Drug Market Share by Region (2027-2032) Table 6. Global Tumor Treatment Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Tumor Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Tumor Treatment Drug Market Size Share by Type (2021-2026) Table 9. Global Tumor Treatment Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Tumor Treatment Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Tumor Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Tumor Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Tumor Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Tumor Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Tumor Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Tumor Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Tumor Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Tumor Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Tumor Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Tumor Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Tumor Treatment Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Tumor Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Tumor Treatment Drug Market Size Share by Application (2021-2026) Table 24. Global Tumor Treatment Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Tumor Treatment Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Tumor Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Tumor Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Tumor Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Tumor Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Tumor Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Tumor Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Tumor Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Tumor Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Tumor Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Tumor Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Tumor Treatment Drug Industry Trends Table 37. Tumor Treatment Drug Industry Drivers Table 38. Tumor Treatment Drug Industry Opportunities and Challenges Table 39. Tumor Treatment Drug Industry Restraints Table 40. Global Tumor Treatment Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Tumor Treatment Drug Revenue Market Share by Company (2021-2026) Table 42. Global Tumor Treatment Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Tumor Treatment Drug Key Company Headquarters & Area Served Table 44. Global Tumor Treatment Drug Company, Product Type & Application Table 45. Global Tumor Treatment Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Tumor Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Astellas Company Information Table 49. Astellas Business Overview Table 50. Astellas Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Astellas Tumor Treatment Drug Product Portfolio Table 52. Astellas Recent Development Table 53. Biogen Idec Company Information Table 54. Biogen Idec Business Overview Table 55. Biogen Idec Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Biogen Idec Tumor Treatment Drug Product Portfolio Table 57. Biogen Idec Recent Development Table 58. Bristol-Myers Squibb Company Information Table 59. Bristol-Myers Squibb Business Overview Table 60. Bristol-Myers Squibb Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bristol-Myers Squibb Tumor Treatment Drug Product Portfolio Table 62. Bristol-Myers Squibb Recent Development Table 63. Celgene Company Information Table 64. Celgene Business Overview Table 65. Celgene Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Celgene Tumor Treatment Drug Product Portfolio Table 67. Celgene Recent Development Table 68. Gilead Sciences Company Information Table 69. Gilead Sciences Business Overview Table 70. Gilead Sciences Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Gilead Sciences Tumor Treatment Drug Product Portfolio Table 72. Gilead Sciences Recent Development Table 73. Ipsen Company Information Table 74. Ipsen Business Overview Table 75. Ipsen Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Ipsen Tumor Treatment Drug Product Portfolio Table 77. Ipsen Recent Development Table 78. Merck & Co. Company Information Table 79. Merck & Co. Business Overview Table 80. Merck & Co. Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Merck & Co. Tumor Treatment Drug Product Portfolio Table 82. Merck & Co. Recent Development Table 83. Otsuka Company Information Table 84. Otsuka Business Overview Table 85. Otsuka Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Otsuka Tumor Treatment Drug Product Portfolio Table 87. Otsuka Recent Development Table 88. AstraZeneca Company Information Table 89. AstraZeneca Business Overview Table 90. AstraZeneca Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. AstraZeneca Tumor Treatment Drug Product Portfolio Table 92. AstraZeneca Recent Development Table 93. AbbVie Company Information Table 94. AbbVie Business Overview Table 95. AbbVie Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AbbVie Tumor Treatment Drug Product Portfolio Table 97. AbbVie Recent Development Table 98. Amgen Company Information Table 99. Amgen Business Overview Table 100. Amgen Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Amgen Tumor Treatment Drug Product Portfolio Table 102. Amgen Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bayer Tumor Treatment Drug Product Portfolio Table 107. Bayer Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Pfizer Tumor Treatment Drug Product Portfolio Table 112. Pfizer Recent Development Table 113. Eli Lilly Company Information Table 114. Eli Lilly Business Overview Table 115. Eli Lilly Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Eli Lilly Tumor Treatment Drug Product Portfolio Table 117. Eli Lilly Recent Development Table 118. Roche Company Information Table 119. Roche Business Overview Table 120. Roche Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Roche Tumor Treatment Drug Product Portfolio Table 122. Roche Recent Development Table 123. Merck KGaA Company Information Table 124. Merck KGaA Business Overview Table 125. Merck KGaA Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Merck KGaA Tumor Treatment Drug Product Portfolio Table 127. Merck KGaA Recent Development Table 128. Novartis Company Information Table 129. Novartis Business Overview Table 130. Novartis Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Novartis Tumor Treatment Drug Product Portfolio Table 132. Novartis Recent Development Table 133. Johnson & Johnson Company Information Table 134. Johnson & Johnson Business Overview Table 135. Johnson & Johnson Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Johnson & Johnson Tumor Treatment Drug Product Portfolio Table 137. Johnson & Johnson Recent Development Table 138. Sanofi Company Information Table 139. Sanofi Business Overview Table 140. Sanofi Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Sanofi Tumor Treatment Drug Product Portfolio Table 142. Sanofi Recent Development Table 143. Teva Company Information Table 144. Teva Business Overview Table 145. Teva Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Teva Tumor Treatment Drug Product Portfolio Table 147. Teva Recent Development Table 148. Eisai Company Information Table 149. Eisai Business Overview Table 150. Eisai Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Eisai Tumor Treatment Drug Product Portfolio Table 152. Eisai Recent Development Table 153. Takeda Company Information Table 154. Takeda Business Overview Table 155. Takeda Tumor Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Takeda Tumor Treatment Drug Product Portfolio Table 157. Takeda Recent Development Table 158. North America Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Tumor Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Tumor Treatment Drug Market Share by Country (2021-2026) Table 161. North America Tumor Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Tumor Treatment Drug Market Share Forecast by Country (2027-2032) Table 163. Europe Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Tumor Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Tumor Treatment Drug Market Share by Country (2021-2026) Table 166. Europe Tumor Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Tumor Treatment Drug Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Tumor Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Tumor Treatment Drug Market Share by Country (2021-2026) Table 171. Asia-Pacific Tumor Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Tumor Treatment Drug Market Share Forecast by Country (2027-2032) Table 173. Latin America Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Tumor Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Tumor Treatment Drug Market Share by Country (2021-2026) Table 176. Latin America Tumor Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Tumor Treatment Drug Market Share Forecast by Country (2027-2032) Table 178. Middle East & Africa Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East & Africa Tumor Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East & Africa Tumor Treatment Drug Market Share by Country (2021-2026) Table 181. Middle East & Africa Tumor Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East & Africa Tumor Treatment Drug Market Share Forecast by Country (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Tumor Treatment Drug Product Image Figure 3. Global Tumor Treatment Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Tumor Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Tumor Treatment Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Tumor Treatment Drug Market Share by Region (2021-2032) Figure 7. North America Tumor Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Tumor Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Tumor Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Tumor Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Tumor Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Immunotherapy (Biologic Therapy) Image Figure 13. Global Immunotherapy (Biologic Therapy) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Chemotherapy Image Figure 15. Global Chemotherapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Hormonal Therapy Image Figure 17. Global Hormonal Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Targeted Therapy Image Figure 19. Global Targeted Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Tumor Treatment Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Tumor Treatment Drug Market Share by Type 2025 VS 2032 Figure 24. North America Tumor Treatment Drug Market Size Share by Type (2021-2032) Figure 25. Europe Tumor Treatment Drug Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Tumor Treatment Drug Market Size Share by Type (2021-2032) Figure 27. Latin America Tumor Treatment Drug Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Tumor Treatment Drug Market Size Share by Type (2021-2032) Figure 29. Respiratory/Lung Cancer Image Figure 30. Global Respiratory/Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Prostate Cancer Image Figure 32. Global Prostate Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Breast Cancer Image Figure 34. Global Breast Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Gastrointestinal Cancer Image Figure 36. Global Gastrointestinal Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Blood Cancer Image Figure 38. Global Blood Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Others Image Figure 40. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global Tumor Treatment Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Tumor Treatment Drug Market Share by Application 2025 VS 2032 Figure 43. North America Tumor Treatment Drug Market Size Share by Application (2021-2032) Figure 44. Europe Tumor Treatment Drug Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific Tumor Treatment Drug Market Size Share by Application (2021-2032) Figure 46. Latin America Tumor Treatment Drug Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa Tumor Treatment Drug Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 Tumor Treatment Drug Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America Tumor Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America Tumor Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America Tumor Treatment Drug Market Share by Country (2021-2032) Figure 53. Europe Tumor Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Tumor Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Tumor Treatment Drug Market Share by Country (2021-2032) Figure 56. Asia-Pacific Tumor Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific Tumor Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific Tumor Treatment Drug Market Share by Country (2021-2032) Figure 59. Latin America Tumor Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Tumor Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Tumor Treatment Drug Market Share by Country (2021-2032) Figure 62. Middle East & Africa Tumor Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa Tumor Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa Tumor Treatment Drug Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapy (Biologic Therapy)
  • Chemotherapy
  • Hormonal Therapy
  • Targeted Therapy
  • Others
Applications
  • Respiratory/Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Blood Cancer
  • Others
Companies covered
  • Astellas
  • Biogen Idec
  • Bristol-Myers Squibb
  • Celgene
  • Gilead Sciences
  • Ipsen
  • Merck & Co.
  • Otsuka
  • AstraZeneca
  • AbbVie
  • Amgen
  • Bayer
  • Pfizer
  • Eli Lilly
  • Roche
  • Merck KGaA
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Teva
  • Eisai
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Tumor Treatment Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Tumor Treatment Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Tumor Treatment Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Tumor Treatment Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Tumor Treatment Drug Market Size (2021-2032)
  8. 1.5.1 North America Tumor Treatment Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Tumor Treatment Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Tumor Treatment Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Tumor Treatment Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Tumor Treatment Drug Market Size Growth Rate (2021-2032)
2 Tumor Treatment Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Immunotherapy (Biologic Therapy)
  3. 2.1.2 Chemotherapy
  4. 2.1.3 Hormonal Therapy
  5. 2.1.4 Targeted Therapy
  6. 2.1.5 Others
  7. 2.2 Global Tumor Treatment Drug Market Size by Type
  8. 2.2.1 Global Tumor Treatment Drug Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Tumor Treatment Drug Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Tumor Treatment Drug Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Tumor Treatment Drug Market Size by Regions
  12. 2.3.1 North America Tumor Treatment Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Tumor Treatment Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Tumor Treatment Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Tumor Treatment Drug Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Tumor Treatment Drug Market Size Breakdown by Type (2021-2026)
3 Tumor Treatment Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Respiratory/Lung Cancer
  3. 3.1.2 Prostate Cancer
  4. 3.1.3 Breast Cancer
  5. 3.1.4 Gastrointestinal Cancer
  6. 3.1.5 Blood Cancer
  7. 3.1.6 Others
  8. 3.2 Global Tumor Treatment Drug Market Size by Application
  9. 3.2.1 Global Tumor Treatment Drug Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Tumor Treatment Drug Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Tumor Treatment Drug Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Tumor Treatment Drug Market Size by Regions
  13. 3.3.1 North America Tumor Treatment Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Tumor Treatment Drug Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Tumor Treatment Drug Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Tumor Treatment Drug Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Tumor Treatment Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Tumor Treatment Drug Industry Trends
  2. 4.2 Tumor Treatment Drug Industry Drivers
  3. 4.3 Tumor Treatment Drug Industry Opportunities and Challenges
  4. 4.4 Tumor Treatment Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Tumor Treatment Drug Revenue (2021-2026)
  2. 5.2 Global Tumor Treatment Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Tumor Treatment Drug Key Company Headquarters & Area Served
  4. 5.4 Global Tumor Treatment Drug Company, Product Type & Application
  5. 5.5 Global Tumor Treatment Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Tumor Treatment Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Tumor Treatment Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Tumor Treatment Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Astellas
  2. 6.1.1 Astellas Company Information
  3. 6.1.2 Astellas Business Overview
  4. 6.1.3 Astellas Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Astellas Tumor Treatment Drug Product Portfolio
  6. 6.1.5 Astellas Recent Developments
  7. 6.2 Biogen Idec
  8. 6.2.1 Biogen Idec Company Information
  9. 6.2.2 Biogen Idec Business Overview
  10. 6.2.3 Biogen Idec Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Biogen Idec Tumor Treatment Drug Product Portfolio
  12. 6.2.5 Biogen Idec Recent Developments
  13. 6.3 Bristol-Myers Squibb
  14. 6.3.1 Bristol-Myers Squibb Company Information
  15. 6.3.2 Bristol-Myers Squibb Business Overview
  16. 6.3.3 Bristol-Myers Squibb Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bristol-Myers Squibb Tumor Treatment Drug Product Portfolio
  18. 6.3.5 Bristol-Myers Squibb Recent Developments
  19. 6.4 Celgene
  20. 6.4.1 Celgene Company Information
  21. 6.4.2 Celgene Business Overview
  22. 6.4.3 Celgene Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Celgene Tumor Treatment Drug Product Portfolio
  24. 6.4.5 Celgene Recent Developments
  25. 6.5 Gilead Sciences
  26. 6.5.1 Gilead Sciences Company Information
  27. 6.5.2 Gilead Sciences Business Overview
  28. 6.5.3 Gilead Sciences Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Gilead Sciences Tumor Treatment Drug Product Portfolio
  30. 6.5.5 Gilead Sciences Recent Developments
  31. 6.6 Ipsen
  32. 6.6.1 Ipsen Company Information
  33. 6.6.2 Ipsen Business Overview
  34. 6.6.3 Ipsen Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Ipsen Tumor Treatment Drug Product Portfolio
  36. 6.6.5 Ipsen Recent Developments
  37. 6.7 Merck & Co.
  38. 6.7.1 Merck & Co. Company Information
  39. 6.7.2 Merck & Co. Business Overview
  40. 6.7.3 Merck & Co. Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Merck & Co. Tumor Treatment Drug Product Portfolio
  42. 6.7.5 Merck & Co. Recent Developments
  43. 6.8 Otsuka
  44. 6.8.1 Otsuka Company Information
  45. 6.8.2 Otsuka Business Overview
  46. 6.8.3 Otsuka Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Otsuka Tumor Treatment Drug Product Portfolio
  48. 6.8.5 Otsuka Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Tumor Treatment Drug Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie Tumor Treatment Drug Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 Amgen
  62. 6.11.1 Amgen Company Information
  63. 6.11.2 Amgen Business Overview
  64. 6.11.3 Amgen Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Amgen Tumor Treatment Drug Product Portfolio
  66. 6.11.5 Amgen Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bayer Tumor Treatment Drug Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Pfizer Tumor Treatment Drug Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 Eli Lilly
  80. 6.14.1 Eli Lilly Company Information
  81. 6.14.2 Eli Lilly Business Overview
  82. 6.14.3 Eli Lilly Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Eli Lilly Tumor Treatment Drug Product Portfolio
  84. 6.14.5 Eli Lilly Recent Developments
  85. 6.15 Roche
  86. 6.15.1 Roche Company Information
  87. 6.15.2 Roche Business Overview
  88. 6.15.3 Roche Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Roche Tumor Treatment Drug Product Portfolio
  90. 6.15.5 Roche Recent Developments
  91. 6.16 Merck KGaA
  92. 6.16.1 Merck KGaA Company Information
  93. 6.16.2 Merck KGaA Business Overview
  94. 6.16.3 Merck KGaA Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Merck KGaA Tumor Treatment Drug Product Portfolio
  96. 6.16.5 Merck KGaA Recent Developments
  97. 6.17 Novartis
  98. 6.17.1 Novartis Company Information
  99. 6.17.2 Novartis Business Overview
  100. 6.17.3 Novartis Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Novartis Tumor Treatment Drug Product Portfolio
  102. 6.17.5 Novartis Recent Developments
  103. 6.18 Johnson & Johnson
  104. 6.18.1 Johnson & Johnson Company Information
  105. 6.18.2 Johnson & Johnson Business Overview
  106. 6.18.3 Johnson & Johnson Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Johnson & Johnson Tumor Treatment Drug Product Portfolio
  108. 6.18.5 Johnson & Johnson Recent Developments
  109. 6.19 Sanofi
  110. 6.19.1 Sanofi Company Information
  111. 6.19.2 Sanofi Business Overview
  112. 6.19.3 Sanofi Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Sanofi Tumor Treatment Drug Product Portfolio
  114. 6.19.5 Sanofi Recent Developments
  115. 6.20 Teva
  116. 6.20.1 Teva Company Information
  117. 6.20.2 Teva Business Overview
  118. 6.20.3 Teva Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Teva Tumor Treatment Drug Product Portfolio
  120. 6.20.5 Teva Recent Developments
  121. 6.21 Eisai
  122. 6.21.1 Eisai Company Information
  123. 6.21.2 Eisai Business Overview
  124. 6.21.3 Eisai Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Eisai Tumor Treatment Drug Product Portfolio
  126. 6.21.5 Eisai Recent Developments
  127. 6.22 Takeda
  128. 6.22.1 Takeda Company Information
  129. 6.22.2 Takeda Business Overview
  130. 6.22.3 Takeda Tumor Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Takeda Tumor Treatment Drug Product Portfolio
  132. 6.22.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Tumor Treatment Drug Market Size by Country (2021-2026)
  3. 7.3 North America Tumor Treatment Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Tumor Treatment Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Tumor Treatment Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Tumor Treatment Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Tumor Treatment Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Tumor Treatment Drug Market Size by Country (2021-2026)
  3. 10.3 South America Tumor Treatment Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Tumor Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Tumor Treatment Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Tumor Treatment Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst